1. The bidirectional relationship between nonalcoholic fatty liver disease and sarcopenia

   • Nghiem B. Ha
   • Jennifer C. Lai

   Editorial 28 March 2022 Pages: 489 - 491

2. Deep learning and non-invasive assessment of significant fibrosis: does adding more toppings improve the flavor of prediction?

   • Nipun Verma
   • Sumeet K. Asrani

   Editorial 31 March 2022 Pages: 492 - 494

   

3. Application of machine learning in liver transplantation: a review

   • Jason Tran
   • Divya Sharma
   • Mamatha Bhat

   Review Article 12 January 2022 Pages: 495 - 508

   

4. Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease

   • Jérémy Dana
   • Aïna Venkatasamy
   • Thomas F. Baumert

   Review Article 09 February 2022 Pages: 509 - 522

   

5. The promise of artificial intelligence for predictive biomarkers in hepatology

   • Mamatha Bhat
   • Madhumitha Rabindranath

   Point-of-View 16 May 2022 Pages: 523 - 525

6. Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network

   • Zhong Liu
   • Huiying Wen
   • Xin Chen

   Original Article 21 March 2022 Pages: 526 - 536

   

7. Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry study

   • Juhan Lee
   • Jae Geun Lee
   • Myoung Soo Kim

   Original Article 23 April 2022 Pages: 537 - 544

   

8. Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study

   • Eun Roh
   • Soon Young Hwang
   • Kyung Mook Choi

   Original Article 15 November 2021 Pages: 545 - 554

   

9. Automated fibrosis phenotyping of liver tissue from non-tumor lesions of patients with and without hepatocellular carcinoma after liver transplantation for non-alcoholic fatty liver disease

   • Yutaka Nakamura
   • Hisamitsu Miyaaki
   • Kazuhiko Nakao

   Original Article 13 May 2022 Pages: 555 - 561

   

10. Tumor–matrix interaction induces phenotypic switching in liver cancer cells

    • Ray-Hwang Yuan
    • Chia-Lang Hsu
    • Yung-Ming Jeng

    Original Article 07 May 2022 Pages: 562 - 576

    

11. Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study

    • Zhikun Liu
    • Yuanpeng Liu
    • Xiao Xu

    Original Article Open access 29 March 2022 Pages: 577 - 589

    

12. Deep learning for evaluation of microvascular invasion in hepatocellular carcinoma from tumor areas of histology images

    • Qiaofeng Chen
    • Han Xiao
    • Shuling Chen

    Original Article Open access 28 March 2022 Pages: 590 - 602

    

13. Actin-related protein 2/3 complex subunit 2-enriched extracellular vesicles drive liver cancer metastasis

    • Piaorong Mei
    • Sze Keong Tey
    • Yi Gao

    Original Article 12 May 2022 Pages: 603 - 613

    

14. miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGFβ receptor 1

    • Yanhua Ma
    • Xiaoxue Yuan
    • Huichun Xing

    Original Article 21 February 2022 Pages: 614 - 626

    

15. Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: an update for image biomarker

    • Jincheng Wang
    • Shengnan Tang
    • Yin Yin

    Original Article Open access 28 March 2022 Pages: 627 - 639

    

16. Gonadal dysfunction in male patients with Budd Chiari syndrome and its reversibility with treatment

    • Nitin Ramani
    • Kashmira Kawli
    • Akash Shukla

    Original Article 17 March 2022 Pages: 640 - 648

    

17. Ultrasonic spleen thickness-based indexes surpass Baveno VI criteria in high-risk gastroesophageal varices detection

    • Xie-Er Liang
    • Xiao-Min Hu
    • Rong-Long Jiang

    Original Article 12 April 2022 Pages: 649 - 657

    

18. Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study

    • Leon Louis Seifert
    • Philipp Schindler
    • Hauke Heinzow

    Original Article Open access 05 April 2022 Pages: 658 - 668

    

19. Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome

    • Xuan Wang
    • Wei Zhang
    • Yuzheng Zhuge

    Original Article Open access 12 January 2022 Pages: 669 - 679

    

20. Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia

    • Srikant Mohta
    • Abhinav Anand
    • Anoop Saraya

    Original Article 25 April 2022 Pages: 680 - 690

    

21. Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

    • Jitao Wang
    • Qiran Zhang
    • Wenhong Zhang

    Original Article 09 April 2022 Pages: 691 - 701

    

22. A rare genetic variant in the manganese transporter SLC30A10 and elevated liver enzymes in the general population

    • Anne-Sofie Seidelin
    • Børge Grønne Nordestgaard
    • Stefan Stender

    Original Article 09 April 2022 Pages: 702 - 711

    

23. Benefit of adjuvant radiotherapy for gallbladder cancer: a comparability-based meta-analysis

    • Seo Hee Choi
    • Chai Hong Rim
    • Jinsil Seong

    Original Article 09 May 2022 Pages: 712 - 727

    

24. The best predictive model for post-SVR HCC: can it be universal?

    • Hidenori Toyoda
    • Masanori Atsukawa

    Letter to the Editor 08 April 2022 Pages: 728 - 728

25. Reply to: The best predictive model for post-SVR HCC: can it be universal?

    • Gamal Shiha
    • N. N. H. Mikhail
    • R. Soliman

    Letter to the Editor 12 May 2022 Pages: 729 - 729

26. The banned herbal medicine induced liver injury in Taiwan

    • Hong-Chun Lin
    • Chien-Ming Yen
    • Ching-Mao Chang

    Letter to the Editor 28 April 2022 Pages: 730 - 731